Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein
PeerJ · 2024
DOI: 10.7717/peerj.17846 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Qian Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, COVID-19. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation, China, Natural Science Foundation of Fujian Province, China, Fujian Medical University.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic, which caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), lead to a crisis with devastating disasters to global public economy and health. Several studies suggest that the SARS-CoV-2 nucleocapsid protein (N protein) is one of uppermost structural constituents of SARS-CoV-2 and is relatively conserved which could become a specific diagnostic marker. In this study, eight single domain antibodies recognized the N protein specifically which were named pN01–pN08 were screened using human phage display library. According to multiple sequence alignment and molecular docking analyses, the interaction mechanism between antibody and N protein was predicted. ELISA results indicated pN01–pN08 with high affinity to protein N. To improve their efficacy, two fusion proteins were prepared and their affinity was tested. These finding showed that fusion proteins had higher affinity than single domain antibodies and will be used as diagnosis for the pandemic of SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
- Fujian Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China.
- Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
- Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
- Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fuzhou, Fujian, China.
Förderung
- National Natural Science Foundation, China
- Natural Science Foundation of Fujian Province, China
- Fujian Medical University
Zitieren
APA
Yang, Q., Yan, M., Lin, J., Lu, Y., Lin, S., Li, Z., Wang, H., Yang, J., Zhang, N., & Chen, X. (2024). Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein. PeerJ. https://doi.org/10.7717/peerj.17846
Vancouver
Yang Q, Yan M, Lin J, Lu Y, Lin S, Li Z, et al. Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein. PeerJ. 2024. doi:10.7717/peerj.17846
BibTeX
@article{Yang2024,
author = {Yang, Qian and Yan, Mengru and Lin, Juan and Lu, Yongkang and Lin, Shuang and Li, Zhong and Wang, He and Yang, Juhua and Zhang, Nanwen and Chen, Xiaole},
title = {Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17846}
}
EUVIMED